This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandmoller, A.
Right arrow Articles by Arnold, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandmoller, A.
Right arrow Articles by Arnold, H. H.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Oct 1996, 5846-5856, Vol 16, No. 10
Copyright © 1996, American Society for Microbiology

A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding

A Sandmoller, H Meents and HH Arnold
Department of Cell and Molecular Biology, University of Braunschweig, Germany. A.Sandmoeller@tu-bs.de

The adenovirus E1A oncoprotein completely blocks muscle differentiation and specifically inhibits the transactivating function of myogenic basic helix-loop-helix (bHLH) transcription factors. This inhibition is dependent on the conserved region CR1 of E1A, which also constitutes part of the binding sites for the pocket proteins pRB, p107, and p130 and the transcriptional coactivators p300 and CBP. Here we report a detailed mutational analysis of E1A and the identification of a muscle inhibition motif within CR1. This motif encompasses amino acids 38 to 62 and inhibits Myf-5- or MyoD-mediated activation of myogenin and the muscle creatine kinase gene. Overexpression of this E1A region also inhibits the conversion of 10T1/2 fibroblasts to the myogenic lineage. The sequence motif EPDNEE (amino acids 55 to 60) within CR1 appears to be particularly important, because point mutations of this sequence diminish the E1A inhibitory activity. Interactions of E1A with pRB and with p300 do not seem to be necessary for the muscle-specific enhancer repression, because E1A mutants which lack these interactions still inhibit Myf-5- and MyoD-mediated transactivation. Moreover, overexpression of p300 fails to overcome muscle-specific inhibition by wild-type E1A and mutant E1A protein which lacks pRB binding. Since we have no evidence for direct E1A interaction with bHLH proteins, we propose that E1A may target a necessary cofactor of the muscle-specific bHLH transcription complex.


This article has been cited by other articles:

  • Samuelson, A. V., Narita, M., Chan, H.-M., Jin, J., de Stanchina, E., McCurrach, M. E., Narita, M., Fuchs, M., Livingston, D. M., Lowe, S. W. (2005). p400 Is Required for E1A to Promote Apoptosis. J. Biol. Chem. 280: 21915-21923 [Abstract] [Full Text]  
  • Goodman, R. H., Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev. 14: 1553-1577 [Full Text]  
  • Riou, P., Bex, F., Gazzolo, L. (2000). The Human T Cell Leukemia/Lymphotropic Virus Type 1 Tax Protein Represses MyoD-dependent Transcription by Inhibiting MyoD-binding to the KIX Domain of p300. A POTENTIAL MECHANISM FOR Tax-MEDIATED REPRESSION OF THE TRANSCRIPTIONAL ACTIVITY OF BASIC HELIX-LOOP-HELIX FACTORS. J. Biol. Chem. 275: 10551-10560 [Abstract] [Full Text]  
  • Xiao, H., Hasegawa, T., Isobe, K.-i. (2000). p300 Collaborates with Sp1 and Sp3 in p21waf1/cip1 Promoter Activation Induced by Histone Deacetylase Inhibitor. J. Biol. Chem. 275: 1371-1376 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»